HansBiomed Corporation - Asset Resilience Ratio

Latest as of March 2025: 9.13%

HansBiomed Corporation (042520) has an Asset Resilience Ratio of 9.13% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩11.75 Billion

≈ $7.96 Million USD Cash + Short-term Investments

Total Assets

₩128.60 Billion

≈ $87.15 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2023)

This chart shows how HansBiomed Corporation's Asset Resilience Ratio has changed over time. Check HansBiomed Corporation PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down HansBiomed Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see HansBiomed Corporation (042520) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩11.75 Billion	9.13%
Short-term Investments	₩0.00	0%
Total Liquid Assets	₩11.75 Billion	9.13%

Asset Resilience Insights

Limited Liquidity: HansBiomed Corporation maintains only 9.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

HansBiomed Corporation Industry Peers by Asset Resilience Ratio

Compare HansBiomed Corporation's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for HansBiomed Corporation (2012–2023)

The table below shows the annual Asset Resilience Ratio data for HansBiomed Corporation.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-09-30	0.75%	₩916.26 Million ≈ $620.93K	₩122.37 Billion ≈ $82.93 Million	-10.63pp
2022-09-30	11.38%	₩14.98 Billion ≈ $10.15 Million	₩131.69 Billion ≈ $89.24 Million	-4.28pp
2021-09-30	15.66%	₩20.27 Billion ≈ $13.74 Million	₩129.44 Billion ≈ $87.72 Million	-2.22pp
2020-09-30	17.88%	₩23.57 Billion ≈ $15.97 Million	₩131.81 Billion ≈ $89.32 Million	+10.12pp
2019-09-30	7.76%	₩10.40 Billion ≈ $7.05 Million	₩134.09 Billion ≈ $90.87 Million	-1.68pp
2018-09-30	9.44%	₩8.66 Billion ≈ $5.87 Million	₩91.80 Billion ≈ $62.21 Million	+3.53pp
2017-09-30	5.90%	₩4.73 Billion ≈ $3.21 Million	₩80.19 Billion ≈ $54.34 Million	+2.61pp
2016-09-30	3.29%	₩2.13 Billion ≈ $1.44 Million	₩64.72 Billion ≈ $43.86 Million	+3.27pp
2015-09-30	0.02%	₩9.04 Million ≈ $6.13K	₩52.11 Billion ≈ $35.32 Million	-0.13pp
2014-09-30	0.15%	₩67.25 Million ≈ $45.58K	₩44.34 Billion ≈ $30.05 Million	-0.09pp
2013-09-30	0.25%	₩81.89 Million ≈ $55.50K	₩33.36 Billion ≈ $22.61 Million	-15.68pp
2012-09-30	15.92%	₩4.31 Billion ≈ $2.92 Million	₩27.05 Billion ≈ $18.33 Million	--

pp = percentage points

About HansBiomed Corporation

KQ:042520 Korea Medical Devices

Market Cap

$164.76 Million

₩243.12 Billion KRW

Market Cap Rank

#17252 Global

#656 in Korea

Share Price

₩18720.00

Change (1 day)

+0.65%

52-Week Range

₩7030.00 - ₩55700.00

All Time High

₩55700.00